NGG NYSE Week ended 07 Aug 2026

Weekly Investor Report

National Grid PLC ADR · Utilities · Utilities - Regulated Electric

Latest close 80.88 USD
1.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 58.7% of its 52-week range. The latest completed week returned 1.1%, after a -2.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. Options positioning is bullish with 44/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 84d.

Setup score 45 out of 100
Latest Close 80.88 USD 7 Aug 2026
1W Return 1.1% latest completed week
4W Return -2.1% short-term follow-through
12W Return 3.0% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 58.08% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 58.7% of its 52-week range. The latest completed week returned 1.1%, after a -2.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3812-week average 0.50

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.38Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.1% over four weeks, 3.0% over 12 weeks, and 18.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.1%
4W-2.1%
12W3.0%
26W-5.7%
52W18.6%
Active trend streak0 weeks
Active weeks in one year44
Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.91Latest activity-pressure read.
Pressure change-17.0%Four-week change in activity pressure.
Leadership-8.42Latest relative-leadership reading.
RS change-96.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength93/100Blend of value, momentum, and quality. Underlying universe rank 8; rank 1 is best.
Value84/100Relative valuation strength. Underlying universe rank 17; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum74/100Medium-term price momentum. Underlying universe rank 27; rank 1 is best.
Growth32/100Revenue and earnings growth. Underlying universe rank 69; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework63/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
13.3x
Price divided by trailing earnings.
Price / sales
2.3x
Market value relative to trailing revenue.
EV / EBITDA
8.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
23.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
29.3%
Gross profit retained from each unit of revenue.
Operating margin
29.0%
Operating profit retained from revenue.
Free-cash-flow margin
84.1%
Free cash flow generated from revenue.
Return on invested capital
9.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
54.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.0%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
4.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

NGG shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.06, expected move of 2.7%, and Sharemaestro trend signal inactive.

Conviction44/100
Expected move2.7%
Put/call volume0.06
Pressure92
Speculation8
Volatility29
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 48 relevant articles.

14 positive · 25 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
Options expected move2.7%Nearest-chain priced movement where available.
52-week drawdown-12.3%Distance below the 52-week high.
13-week volatility3.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+7.4%Week of 3 Apr.
Worst week-9.8%Week of 20 Mar.
Latest week+1.1%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains8
Flat weeks0
Modest losses11
Sharp losses3
Recent vol3.5%13-week weekly-return volatility.
Base vol3.1%52-week weekly-return volatility.
Up/down split28/23Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202680.88 USD1.1%83.65 USD64.95 USD-0.91-8.423.7MOff
31 Jul 202679.97 USD-2.8%83.55 USD64.76 USD-0.89-6.324.0MOff
24 Jul 202682.30 USD-2.0%83.44 USD64.58 USD-0.76-2.623.7MOff
17 Jul 202683.99 USD1.7%83.22 USD64.40 USD-0.64-1.184.0MOff
10 Jul 202682.59 USD-0.3%82.89 USD64.22 USD-0.78-4.293.8MOff
3 Jul 202682.85 USD-0.2%82.57 USD64.05 USD-0.83-2.684.5MOff
26 Jun 202683.01 USD4.5%82.26 USD63.85 USD-0.93-0.387.8MOff
19 Jun 202679.44 USD-2.9%81.96 USD63.67 USD-1.13-6.975.8MOff
12 Jun 202681.84 USD-0.0%81.76 USD63.51 USD-0.97-3.424.3MOn
5 Jun 202681.86 USD0.4%81.50 USD63.34 USD-0.85-2.975.5MOn
29 May 202681.53 USD-3.4%81.27 USD63.17 USD-0.79-5.844.2MOn
22 May 202684.36 USD7.4%80.96 USD62.99 USD-0.66-1.328.3MOn
15 May 202678.55 USD-7.2%80.61 USD62.80 USD-0.64-7.4518.6MOn
8 May 202684.63 USD-1.8%80.45 USD62.64 USD-0.65-0.194.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context